UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (23), p.9742-9754

2010

Volltextzugriff (PDF)

An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

Breast cancer research : BCR, 2015-04, Vol.17 (1), p.61, Article 61

2015

Volltextzugriff (PDF)

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Cancer epidemiology, biomarkers & prevention, 2012-01, Vol.21 (1), p.134-147

2012

Volltextzugriff (PDF)

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

Nature genetics, 2017-05, Vol.49 (5), p.680-691

2017

Volltextzugriff (PDF)

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Nature genetics, 2017-12, Vol.49 (12), p.1767-1778

2017

Volltextzugriff (PDF)

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

Nature genetics, 2013-04, Vol.45 (4), p.371-384

2013

Volltextzugriff (PDF)

Identification of six new susceptibility loci for invasive epithelial ovarian cancer

Nature genetics, 2015-02, Vol.47 (2), p.164-171

2015

Volltextzugriff (PDF)

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170

Nature genetics, 2016-04, Vol.48 (4), p.374-386

2016

Volltextzugriff (PDF)

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

PLoS genetics, 2013, Vol.9 (3), p.e1003212-e1003212

2013

Volltextzugriff (PDF)

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

Nature communications, 2016-04, Vol.7 (1), p.11375-13, Article 11375

2016

Volltextzugriff (PDF)

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

JNCI : Journal of the National Cancer Institute, 2016-02, Vol.108 (2), p.djv315

2016

Volltextzugriff (PDF)

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus

Nature communications, 2016-09, Vol.7 (1), p.12675-22, Article 12675

2016

Volltextzugriff (PDF)

Features of anxiety in primary school children with mental retardation in conditions of inclusive and integrated learning

Journal of Pedagogical Studies, 2024-06, Vol.9 (2), p.77-90

2024

Volltextzugriff (PDF)

Strong founder effects in BRCA1 mutation carrier breast cancer patients from Latvia. Mutation in brief no. 258. Online

Human mutation, 1999, Vol.14 (1), p.92-92

1999

Volltextzugriff (PDF)

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

Breast cancer research : BCR, 2014-12, Vol.16 (6), p.3416-3416, Article 3416

2014

Volltextzugriff (PDF)

Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

Breast cancer research : BCR, 2016-06, Vol.18 (1), p.64, Article 64

2016

Volltextzugriff (PDF)

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

Breast cancer research : BCR, 2012-01, Vol.14 (1), p.R33-R33

2012

Volltextzugriff (PDF)

Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

Breast cancer research and treatment, 2017-01, Vol.161 (1), p.117-134

2017

Volltextzugriff (PDF)

Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

PloS one, 2016-07, Vol.11 (7), p.e0158801-e0158801

2016

Volltextzugriff (PDF)

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

Gynecologic oncology, 2016-05, Vol.141 (2), p.386-401

2016

Volltextzugriff (PDF)

Analysis of point mutations of the BRCA1 gene by hybridization with hydrogel microarrays

Molecular biology (New York), 2006-01, Vol.40 (1), p.25-29

2006

Volltextzugriff (PDF)

Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers

Breast cancer research and treatment, 2012-11, Vol.136 (1), p.295-302

2012

Volltextzugriff (PDF)

Hereditary Breast Cancer in Latvia: Mutation Analysis of the BRCA1 Gene

Disease markers, 1999-01, Vol.15 (1-3), p.97-97

1999

Volltextzugriff (PDF)

1044 High incidence of mutations in BRCA1 in breast and ovarian cancer patients in Latvia

European journal of cancer supplements, 2003-09, Vol.1 (5), p.S311-S312

2003

Volltextzugriff (PDF)

DNA diagnosis of hereditary breast and ovarian cancer in Latvia

European journal of cancer supplements, 2004-03, Vol.2 (3), p.103-103

2004

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

Identification of six new susceptibility loci for invasive epithelial ovarian cancer

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus

Features of anxiety in primary school children with mental retardation in conditions of inclusive and integrated learning

Strong founder effects in BRCA1 mutation carrier breast cancer patients from Latvia. Mutation in brief no. 258. Online

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

Analysis of point mutations of the BRCA1 gene by hybridization with hydrogel microarrays

Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers

Hereditary Breast Cancer in Latvia: Mutation Analysis of the BRCA1 Gene

1044 High incidence of mutations in BRCA1 in breast and ovarian cancer patients in Latvia

DNA diagnosis of hereditary breast and ovarian cancer in Latvia

Suchergebnisse filtern